A Pilot Study of Riluzole vs. Placebo in the Treatment of Children and Adolescents With Autism Spectrum ASD (Rilise)

Trial Profile

A Pilot Study of Riluzole vs. Placebo in the Treatment of Children and Adolescents With Autism Spectrum ASD (Rilise)

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Mar 2017

At a glance

  • Drugs Riluzole (Primary)
  • Indications Pervasive child development disorders
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms RILISE
  • Most Recent Events

    • 12 Apr 2016 Status changed from active, no longer recruiting to completed.
    • 29 Dec 2015 Planned End Date changed from 1 Feb 2016 to 1 Mar 201 as reported by ClinicalTrials.gov record.
    • 04 Sep 2015 Planned End Date changed from 1 Dec 2015 to 1 Feb 2016, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top